Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician

Critical Reviews in Clinical Laboratory Sciences

Volumn 52, Issue 1, 2015, Pages 28-44

  Hickman, Peter E ^a,b   Lindahl, Bertil ^c   Cullen, Louise ^d,e   Koerbin, Gus ^f,g   Tate, Jill ^d   Potter, Julia M ^a,b  

^a ACT Pathology ^*  (Australia)

^b Canberra Hospital   (Australia)

^c UPPSALA UNIVERSITY   (Sweden)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^f UNIVERSITY OF CANBERRA   (Australia)

^g Institute of Clinical Pathology and Medical Research   (Australia)

Author keywords

99th Percentile; Acute coronary syndrome; Cardiac troponin; Delta change; Index of individuality; Reference change value

Indexed keywords

BIOLOGICAL MARKER; TROPONIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADVERSE OUTCOME; AGE; CARDIOLOGIST; EMERGENCY WARD; ETHNICITY; HUMAN; LIMIT OF DETECTION; MEASUREMENT; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; REVIEW; SEX DIFFERENCE; BLOOD; CARDIOLOGY; EMERGENCY MEDICINE; HEART MUSCLE; IMMUNOASSAY; METABOLISM; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PROCEDURES; STANDARDS;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CARDIOLOGY; EMERGENCY MEDICINE; HUMANS; IMMUNOASSAY; MYOCARDIAL INFARCTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; TROPONIN;

EID: 84921281009     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2014.972497     Document Type: Review

References (137)

1. Katus HA, Remppis A, Looser S, et al. Enzyme linked immunoassay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989;21:1349-53.
2. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation 2000;102:1216-20.
3. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36: 959-69.
4. Apple FS, Wu AHB. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001;47:377-9.
5. Wu AHB, Apple FS, Gibler WB, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.
6. Herren KR, Mackway-Jones K, Richards CR, et al. Is it possible to exclude a diagnosis of myocardial damage within six hours of admission to an emergency department? Diagnostic cohort study. Brit Med J 2001;323:1-4.
7. Fox KAA, Birkhead J, Wilcox R, et al. British Cardiac Society Working Group on the definition of myocardial infarction. Heart 2004;90:603-9.
8. Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organisation definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011;40:139-46.
9. Braunwald E, Morrow DA. Unstable angina. Is it time for a requiem? Circulation 2013;127:2452-7.
10. Thygesen, K Alpert JS, Jaffe AS, et al. White HD: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation 2012;16: 2020-35.
11. Melberg T, Burman R, Dickstein K. The impact of the 2007 ESC-ACC- AHA-WHF Universal Definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol 2010;139:228-33.
12. Javed U, Aftab W, Ambrose JA, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 2009;104:9-13.
13. Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013;126:789-97.
14. Hamm CW, Braunwald E. A classification of unstable angina. Circulation 2000;102:118-22.
15. Alpert JS, Thygesen KA, White HD, Jaffe AS. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med 2014;127:105-8.
16. Jaffe AS, Landt Y, Parvin CA, et al. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin Chem 1996;42: 1770-6.
17. Apple FS, Sharkey SW, Falahati A, et al. Assessment of left ventricular function using serum cardiac troponin I measurements following myocardial infarction. Clin Chim Acta 1998;272:59-67.
18. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996;93:1651-7.
19. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA investigators. N Engl J Med 1996;335: 1333-41.
20. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
21. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. C7E3 Fab antiplatelet therapy in unstable refractory angina (CAPTURE) study investigators. N Engl J Med 1999;340:1623-9.
22. Heeschen C, Hamm CW, Goldmann B, et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM study investigators: platelet receptor inhibition in ischemic syndrome management. Lancet 1999;354:1757-62.
23. Newby LK, Ohman EM, Christenson RH, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the paragon-B troponin T substudy. Circulation 2001;103:2891-6.
24. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. J Am Med Assoc 2001;286:2405-12.
25. Lindahl B, Diderholm E, Lagerqvist B, et al. Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease - a FRISC II substudy. J Am Coll Cardiol 2001;38:979-86.
26. Mills NL, Churchhouse AM, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of myocardial infarction and death in patients with suspected acute coronary syndrome. J Am Med Assoc 2011;305:1210-16.
27. Koerbin G, Potter JM, Abhayaratna WP, et al. The distribution of cardiac troponin I in a cohort of healthy children: lessons for adults. Clin Chim Acta 2013;417:54-6.
28. Koerbin G, Abhayaratna WP, Potter JM, et al. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem 2013;46:1636-43.
29. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I Access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54:1165-72.
30. Kavsak PA, Macrae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009; 55:573-7.
31. Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
32. Ooi DS, Veinot JP, Wells GA, House AA. Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study. Clin Biochem 1999;32:647-52.
33. Dierkes J, Domrose U, Westphal S, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000;102:1964-9.
34. Anderson PA, Malouf NN, Oakeley AE, et al. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res 1991;69:1226-33.
35. Jaffe AS, Vasile VC, Milone M, et al. Diseased skeletal muscle: a non-cardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol 2011;18:1819-24.
36. Rittoo D, Jones A, Lecky B, Neithercut D. Elevation of cardiac troponin T but not cardiac troponin I in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction. J Am Coll Cardiol 2014;63:2411-20.
37. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
38. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574-81.
39. Lam Q, Black M, Youdell O, et al. Performance Evaluation and Subsequent Clinical Experience with the Abbott Automated Architect STAT Troponin-I Assay. Clin Chem 2006; 52:298-300.
40. Apple FS, Murakami MM. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays. Clin Chem 2007;53:1558-60.
41. Koerbin G, Tate J, Potter JM, et al. Characterization of a highly sensitive TnI assay and its application to a cardio-healthy population. Clin Chem Lab Med 2012;50:871-8.
42. Aw TC, Phua SK, Tan SP. Measurement of cardiac troponin I in serum with a new high sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender. Clin Chim Acta 2013;422: 26-8.
43. Apple FS, Murakami MM. Serum 99th percentile reference cutoffs for seven cardiac troponin assays. Clin Chem 2004;50: 1477-9.
44. Eggers KM, Jaffe AS, Lind L, et al. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009;55:85-92.
45. Zaninotto M, Mion MM, Novello E, et al. Precision performance at low levels and 99th percentile concentration of the Access AccuTnl assay on two different platforms. Clin Chem Lab Med 2009;47:367-71.
46. Saw S, Wang C, Sethi S. Meeting the challenge of the ESC/ACC definition of myocardial infarction of the new troponin I ES on the VITROS R 5600 integrated system and VITROS R ECi immunodiagnostic system [Abstract]. Clin Chem 2009;55:B51.
47. Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56: 254-61.
48. Aw TC, Pua SK, Yew L, et al. Performance of a new rapid automated high-sensitive troponin T (hsTnT) immunoassay [Abstract]. Clin Chem 2010;56:C88.
49. Collinson PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219-25.
50. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
51. McKie PM, Heublein DM, Scott CG, et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem 2013;59:1099-107.
52. Christenson RH, Cervelli DR, Bauer RS, Gordon M. Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations. Clin Biochem 2004;37:679-83.
53. Apple FS, Simpson PA, Murakami MM. Defining the serum 99th percentile in a normal reference population measured by a highsensitivity cardiac troponin I assay. Clin Biochem 2010;43: 1034-6.
54. Gore MO, Seliger SL, DeFilippi CR, et al. Age-and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 2014;63:1441-8.
55. Gaggin HK, Dang PV, Do LD, et al. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: the North South East West trial. Clin Chem 2014;60:758-64.
56. Schneider HG, Tate JR, Hickman PE. What criteria should be used to assess troponin assays? Clin Chem 2010;56:140-2.
57. Venge P, Johnston N, Lagerqvist B, et al. Clinical and analytical performance of the Liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. a FRISC-II substudy. Clin Chem 2003;49:880-6.
58. Doesch AO, Mueller S, Nelles M, et al. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy. Basic Res Cardiol 2011;106:25-35.
59. Lindahl B, Venge P, Eggers KM, et al. Autoantibodies to cardiac troponin in acute coronary syndromes. Clin Chim Acta 2010;411: 1793-8.
60. Savukoski T, Ilva T, Lund J, et al. Autoantibody prevalence with an improved immunoassay for detecting cardiac troponin-specific autoantibodies. Clin Chem Lab Med 2014;52:273-9.
61. Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002;325:1-15.
62. Michielsen EC, Bisschops PG, Janssen MJ. False positive troponin result caused by a true macrotroponin. Clin Chem Lab Med 2011; 49:923-5.
63. Lippi G, Aloe R, Meschi T, et al. Interference for heterophilic antibodies in troponin testing. Case report and systematic review of the literature. Clin Chim Acta 2013;426:79-84.
64. Gunnewiek JM, Van Der Hoeven JG. Cardiac troponin elevations among critically ill patients. Curr Opin Crit Care 2004;10:342-6.
65. Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and acute heart failure. Clin Chem 2009;55:2098-112.
66. Pierpont GL, McFalls EO. Interpreting troponin elevations: do we need multiple diagnoses? Eur Heart J 2009;30:135-8.
67. Ilva TJ, Eskola MJ, Nikus KC, et al. The etiology and prognostic significance of cardiac troponin I elevation in unselected emergency department patients. J Emerg Med 2010;38:1-5.
68. Sandoval Y, Apple FS. The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem 2014;60: 455-62.
69. Selker HP, Beshansky JR, Griffith JL, et al. Use of the acute cardiac ischemia time-insensitive predictive instrument (ACITIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia: a multicenter, controlled clinical trial. Ann Intern Med 1998;129:845-55.
70. Goldman L, Kirtane AJ. Triage of patients with acute chest pain and possible cardiac ischemia: the elusive search for diagnostic perfection. Ann Intern Med 2003;139:987-95.
71. Lindsell C, Anantharaman V, Diercks D, et al. The internet tracking registry of acute coronary syndromes (itrACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med 2006;48:666-77.
72. Parsonage WA, Greenslade JH, Hammett CJ, et al. Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain. Med J Aust 2014;200:161-5.
73. Kelly AM, Klim S. What is the 30-day rate of adverse cardiac events in chest pain patients with ED troponin I assays ≤99th centile using a contemporary sensitive assay? An exploratory analysis. Eur J Emerg Med 2014;21:276-80.
74. Than M, Cullen L, Aldous S, et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol 2012;59:2091-8.
75. Than M, Herbert M, Flaws D, et al. What is an acceptable risk of a major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department? A clinical survey. Int J Cardiol 2013;166:752-4.
76. Collinson PO, Van Dieijen-Visser MP, Pulkki K, et al. Evidencebased laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CAMARGUE) study. Clin Chem 2012;58: 305-14.
77. Cardinaels EPM, Mingels AMA, Jacobs LHJ, et al. A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead. Clin Chem Lab Med 2012;50:791-806.
78. Hickman PE, Lindahl B, Potter JM, et al. Is it time to do away with the 99th percentile for cardiac troponin for diagnosis of the acute coronary syndrome and in the assessment of cardiac risk? Clin Chem 2014;60:734-6.
79. Morrow DA, Rifai N, Sabatine MS, et al. Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes. Clin Chem 2003;49:1396-8.
80. James S, Armstrong P, Califf R, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003; 115:178-84.
81. Kavsak PA, Xu L, Yusuf S, McQueen MJ. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem 2011;57:1146-53.
82. May EAB, Bonaca MP, Jarolim P, et al. Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-STelevation acute coronary syndromes. Clin Chem 2014;60:158-64.
83. Tate JR, Heathcote D, Rayfield J, Hickman PE. The lack of standardization of cardiac troponin I assay systems. Clin Chim Acta 1999;284:141-9.
84. Tate JR, Bunk DM, Christenson RH, et al. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010;42:402-8.
85. Hallermeyer K, Jarausch J, Menassanch-Volker S, Ziegler A. Implications of adjustment of high-sensitivity cardiac troponin T assay. Clin Chem 2013;59:572-4.
86. Parsonage WA, Tate JR, Greenslade JH, et al. Effect of recalibration of the hs-TnT assay on diagnostic performance. Clin Chem Lab Med 2014;52:e25-7.
87. Fraser CG. Biological Variation: From Principles to Practice. Washington, DC: AACC Press; 2001.
88. Simpson AJ, Potter JM, Koerbin G, et al. Use of observed within-person variation of cardiac troponin in Emergency Department patients for determination of biological variation and percentage and absolute reference change values. Clin Chem 2014;60:848-54.
89. Koerbin GL, Potter JM, Abhayaratna WP, et al. Longitudinal studies of cardiac troponin I in a large cohort of healthy children. Clin Chem 2012;58:1665-72.
90. Apple FS, Murakami MM, Wilans FH, et al. Short-term biological variation of cardiac troponin I measured with three high-sensitivity assays. Clin Chem 2011;57:C-05.
91. Goldberg J, Iriate B, Prostko J, et al. Short and long-term biological variation of troponin I determined using the ARCHITECT STAT high sensitive troponin I assay. Clin Chem 2011;57:C04.
92. Nordenskjold AM, Ahlstrom H, Eggers KM, et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem 2013;59:401-9.
93. Wu AH, Lu QA, Todd J, et al. Short and long-term biological variation in cardiac troponin measured with a high sensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-8.
94. Wu AH, Akhigbe P, Wians F. Long-term biological variation in cardiac troponin. Clin Biochem 2012;45:714-16.
95. Scharnhorst V, Krasznai K, van't Veer M, Michels RH. Variations of cardiac troponin I and T measured with sensitive assays in Emergency Department patients with noncardiac chest pain. Clin Chem 2012;58:1208-14.
96. Aakre KM, Rorass T, Petersen PH, et al. Weekly and 90-minute biological variations in cardiac troponin I in haemodialysis patients and normal controls. Clin Chem 2014;60:838-47.
97. Vasile VC, Saenger AK, Kroning AM, et al. Biological variation of a novel cardiac troponin I assay. Clin Chem 2011;57:1080-1.
98. Vasile VC, Saenger AK, Kroning AM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086-91.
99. Frankenstein L, Wu AH, Hallermayer K, et al. Biological variation and reference change values of high sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem 2011;57:1068-71.
100. Klinkenberg LJ, van Dijk JW, Tan FE, et al. Circulating cardiac troponin T exhibits diurnal rhythm. J Am Coll Cardiol 2014;63: 1788-95.
101. Normann J, Mueller M, Biener M, et al. Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department. Am Heart J 2012;164:698-705.
102. Eggers K, Lind L, Venge P, Lindahl B. Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age. Clin Chem 2013; 59:1068-73.
103. Keller T, Ojeda F, Zeller T, et al. Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay. Int J Cardiol 2013;167:1423-9.
104. Eggers KM, Venge P, Lindahl B, Lind L. Cardiac troponin I levels measured over time with a high sensitivity assay increase over time and are strong predictors of mortality in an elderly population. J Am Coll Cardiol 2013;61:1906-13.
105. Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left ventricular mass in a healthy population (The Framingham Study). Am J Cardiol 1989;64:1066-8.
106. Apple FS, Smith SW, Pearce LA, Murakami MM. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVA Centaur TnI-Ultra assay. Clin Biochem 2012;45:711-13.
107. Lipowski CA, Laird D, Workman R, et al. Development of a highly sensitive immunoassay for cardiac troponin I for the ARCHITECT i2000SR and i1000SR analyzers. Clin Chem 2012; 58:A5.
108. Saenger AK, Beyrau R, Braun S, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412:748-54.
109. Hvelplund A, Galatius S, Madsen M, et al. Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. Eur Heart J 2010;31:684-90.
110. Jacobs AK. Coronary intervention in 2009: are women no different than men? Circ Cardiovasc Interv 2009;2:69-78.
111. Hickman PE, Badrick T, Wilson SR, McGill D. Reporting of cardiac troponin - problems with the 99th population percentile. Clin Chim Acta 2007;381:182-3.
112. Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008;46:1489-500.
113. De Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. J Am Med Assoc 2010;304:2503-12.
114. Abbott ARCHITECT STAT High Sensitive Troponin-I [Package Insert]. Chicago, IL: Abbott Laboratories; 2012.
115. CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. 3rd ed. CLSI document C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
116. Abhayaratna WP, Marwick TH, Becker NG, et al. Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide. Am Heart J 2006;152: 941-8.
117. Baggish AL, Cameron R, Anwaruddin S, et al. A clinical and biochemical critical pathway for the evaluation of patients with suspected acute congestive heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) algorithm. Crit Pathw Cardiol 2004;3:171-6.
118. Body R, Carley S, McDowell G, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011;58:1332-9.
119. Rubini-Gimenez M, Hoeller R, Reichlin T, et al. Rapid rule out of myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol 2013;168:3896-901.
120. Bandstein N, Ljung R, Johansson M, Holzmann MJ. Undetectable high sensitivity troponin T level in the Emergency Department and risk of myocardial infarction. J Am Coll Cardiol 2014;63: 2569-78.
121. Jaffe AS, Apple FS, Morrow DA, et al. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction. Clin Chem 2010;56:941-3.
122. Spencer CA. Thyroid profiling for the 1990s: free T4 estimate or sensitive TSH measurement. J Clin Immunoassay 1989;12:82-9.
123. Fesmire FM. Improved identification of acute coronary syndromes with delta cardiac serum marker measurements during the emergency department evaluation of chest pain patients. Cardiovasc Toxicol 2001;1:117-23.
124. Apple FS, Pearce LA, Smith SW, et al. Role of monitoring changes in sensitive troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 2009;55:930-7.
125. Aldous S, Pemberton C, Richards AM, et al. High-sensitivity troponin T for early rule-out of myocardial infarction in recent onset chest pain. Emerg Med J 2012;29:805-10.
126. Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124: 136-45.
127. Mueller M, Biener M, Vafaie M, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58:209-18.
128. Biener M, Mueller M, Vafaie M, et al. Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population. Int J Cardiol 2013;167: 1134-40.
129. Cullen L, Parsonage WA, Greenslade J, et al. Delta troponin for the early diagnosis of AMI in emergency patients. Int J Cardiol 2013;168:2602-8.
130. Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012;172:1211-18.
131. Cullen L, Mueller C, Parsonage WA, et al. Validation of highsensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013;62:1242-9.
132. Arenja N, Mueller C, Ehl NF, et al. Prevalence, extent and independent predictors of silent myocardial infarction. Am J Med 2013;126:515-22.
133. Biener M, Mueller M, Vafaie M, et al. Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity troponin T in an unselected emergency department population. Eur Heart J Acute Cardiovasc Care 2013;2: 314-22.
134. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post discharge death in an international registry. J Am Med Assoc 2004;291:2727-33.
135. Antman EM, Cohen MK, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI. J Am Med Assoc 2000; 284:835-42.
136. Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J 2008;16:191-6.
137. Than M, Flaws D, Sanders S, et al. Development and validation of the Emergency Department Assessment of Chest Pain Score and 2 h accelerated diagnostic protocol. Emerg Med Australas 2014;26: 34-44.